151 related articles for article (PubMed ID: 17210994)
21. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
Yu JC; Hsu HM; Chen ST; Hsu GC; Huang CS; Hou MF; Fu YP; Cheng TC; Wu PE; Shen CY
J Biomed Sci; 2006 May; 13(3):419-32. PubMed ID: 16502042
[TBL] [Abstract][Full Text] [Related]
23. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.
Kim HS; Park KH; Kim SA; Wen J; Park SW; Park B; Gham CW; Hyung WJ; Noh SH; Kim HK; Song SY
Mutat Res; 2005 Oct; 578(1-2):187-201. PubMed ID: 16112690
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer.
Dai Q; Cai QY; Shu XO; Ewart-Toland A; Wen WQ; Balmain A; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2065-70. PubMed ID: 15598762
[TBL] [Abstract][Full Text] [Related]
26. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
[TBL] [Abstract][Full Text] [Related]
27. Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk.
Kuschel B; Auranen A; Gregory CS; Day NE; Easton DF; Ponder BA; Dunning AM; Pharoah PD
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):809-12. PubMed ID: 12917215
[TBL] [Abstract][Full Text] [Related]
28. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
29. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
32. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
To-Ho KW; Cheung HW; Ling MT; Wong YC; Wang X
Oncogene; 2008 Jan; 27(3):347-57. PubMed ID: 17621272
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
34. Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?
Jakubowska A; Jaworska K; Cybulski C; Janicka A; Szymańska-Pasternak J; Lener M; Narod SA; Lubiński J;
Eur J Cancer; 2009 Mar; 45(5):837-42. PubMed ID: 19071013
[TBL] [Abstract][Full Text] [Related]
35. CHFR-associated early G2/M checkpoint defects in breast cancer cells.
Erson AE; Petty EM
Mol Carcinog; 2004 Jan; 39(1):26-33. PubMed ID: 14694445
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms in centrobin and Nek2 are associated with breast cancer susceptibility in a Chinese Han population.
Wang H; Xie YT; Han JY; Ruan Y; Song AP; Zheng LY; Zhang WZ; Sajdik C; Li Y; Tian XX; Fang WG
Breast Cancer Res Treat; 2012 Nov; 136(1):241-51. PubMed ID: 23001753
[TBL] [Abstract][Full Text] [Related]
37. 'Hide-then-hit' to explain the importance of genotypic polymorphism of DNA repair genes in determining susceptibility to cancer.
Wu PE; Shen CY
J Mol Cell Biol; 2011 Feb; 3(1):59-65. PubMed ID: 21278453
[TBL] [Abstract][Full Text] [Related]
38. Low cdc27 and high securin expression predict short survival for breast cancer patients.
Talvinen K; Karra H; Pitkänen R; Ahonen I; Nykänen M; Lintunen M; Söderström M; Kuopio T; Kronqvist P
APMIS; 2013 Oct; 121(10):945-53. PubMed ID: 23755904
[TBL] [Abstract][Full Text] [Related]
39. Bone morphogenetic protein (BMP) signaling regulates mitotic checkpoint protein levels in human breast cancer cells.
Yan H; Zhu S; Song C; Liu N; Kang J
Cell Signal; 2012 Apr; 24(4):961-8. PubMed ID: 22234345
[TBL] [Abstract][Full Text] [Related]
40. Genetic variation in the major mitotic checkpoint genes and risk of breast cancer: a multigenic study on cancer susceptibility.
Wang P; Wang Y; Yan H; Xie Q; Zhao L; Xu S; Zhao Q
Tumour Biol; 2014 Jul; 35(7):6701-5. PubMed ID: 24711138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
